Expression of mutant type-p53 products in H pylori-associated chronic gastritis

World Journal of Gastroenterology

Volumn 13, Issue 10, 2007, Pages 1541-1546

  Kodama, Masaaki ^a   Murakami, Kazunari ^a   Okimoto, Tadayoshi ^a   Sato, Ryugo ^a   Watanabe, Koichiro ^a   Fujioka, Toshio ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Atrophic gastritis; Gastric cancer; H pylori; H pylori eradication; Mutant type p53; Updated Sydney system

Indexed keywords

ANTIBIOTIC AGENT; POLYCLONAL ANTIBODY; PROTEIN P53;

ADULT; AGED; ARTICLE; BACTERIAL CELL; CELL COUNT; CHRONIC GASTRITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ERADICATION THERAPY; FEMALE; GASTROINTESTINAL TRACT EXAMINATION; GASTROSCOPY; GENE EXPRESSION; GENE MUTATION; GENETIC STABILITY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; MUSCLE ATROPHY; SCORING SYSTEM; STOMACH ANTRUM; STOMACH BIOPSY; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH MUCOSA; STOMACH MUSCLE; TREATMENT OUTCOME;

EID: 34247599716     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i10.1541     Document Type: Article

References (34)

1. Marshall BJ, Armstrong JA, McGechie DB, Glancy RJ. Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med J Aust 1985; 142: 436-439
2. Morris A, Nicholson G. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol 1987; 82: 192-199
3. Fujioka T, Kubota T, Shuto R, Kodama R, Murakami K, Perparim K, Nasu M. Establishment of an animal model for chronic gastritis with Helicobacter pylori: potential model for long-term observations. Eur J Gastroenterol Hepatol 1994; 6 Suppl 1: S73-S78
4. Kuipers EJ, Uyterlinde AM, Pena AS, Roosendaal R, Pals G, Nelis GF, Festen HP, Meuwissen SG. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995; 345: 1525-1528
5. Sakaki N, Momma K, Egawa N, Yamada Y, Kan T, Ishiwata J. The influence of Helicobacter pylori infection on the progression of gastric mucosal atrophy and occurrence of gastric cancer. Eur J Gastroenterol Hepatol 1995; 7 Suppl 1: S59-S62
6. Schubert TT, Bologna SD, Nensey Y, Schubert AB, Mascha EJ, Ma CK. Ulcer risk factors: interactions between Helicobacter pylori infection, nonsteroidal use, and age. Am J Med 1993; 94: 413-418
7. Maaroos HI, Kekki M, Vorobjova T, Salupere V, Sipponen P. Risk of recurrence of gastric ulcer, chronic gastritis, and grade of Helicobacter pylori colonization. A long-term follow-up study of 25 patients. Scand J Gastroenterol 1994; 29: 532-536
8. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, Isaacson PG. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575-577
9. Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet 1998; 352: 878
10. Sato R, Murakami K, Watanabe K, Okimoto T, Miyajima H, Ogata M, Ohtsuka E, Kodama M, Saburi Y, Fujioka T, Nasu M. Effect of Helicobacter pylori eradication on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura. Arch Intern Med 2004; 164: 1904-1907
11. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-789
12. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology 1998; 115: 642-648
13. Honda S, Fujioka T, Tokieda M, Satoh R, Nishizono A, Nasu M. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res 1998; 58: 4255-4259
14. Murakami K, Fujioka T, Okimoto T, Mitsuishi Y, Oda T, Nishizono A, Nasu M. Analysis of p53 gene mutations in Helicobacter pylori-associated gastritis mucosa in endoscopic biopsy specimens. Scand J Gastroenterol 1999; 34: 474-477
15. Chiou CC, Chan CC, Sheu DL, Chen KT, Li YS, Chan EC. Helicobacter pylori infection induced alteration of gene expression in human gastric cells. Gut 2001; 48: 598-604
16. Backert S, Gressmann H, Kwok T, Zirrmy-Arndt U, Konig W, Jungblut PR, Meyer TF. Gene expression and protein profiling of AGS gastric epithelial cells upon infection with Helicobacter pylori. Proteomics 2005; 5: 3902-3918
17. Mannick EE, Schurr JR, Zapata A, Lentz JJ, Gastanaduy M, Cote RL, Delgado A, Correa P, Correa H. Gene expression in gastric biopsies from patients infected with Helicobacter pylori. Scand J Gastroenterol 2004; 39: 1192-1200
18. Kodama M, Fujioka T, Murakami K, Okimoto T, Sato R, Watanabe K, Nasu M. Eradication of Helicobacter pylori reduced the immunohistochemical detection of p53 and MDM2 in gastric mucosa. J Gastroenterol Hepatol 2005; 20: 941-946
19. Kodama M, Fujioka T, Kodama R, Takahashi K, Kubota T, Murakami K, Nasu M. p53 expression in gastric mucosa with Helicobacter pylori infection. J Gastroenterol Hepatol 1998; 13: 215-219
20. Correa P, Shiao YH. Phenotypic and genotypic events in gastric carcinogenesis. Cancer Res 1994; 54: 1941s-1943s
21. Tahara E, Kuniyasu H, Yasui W, Yokozaki H. Gene alterations in intestinal metaplasia and gastric cancer. Eur J Gastroenterol Hepatol 1994; 6 Suppl 1: S97-SlOZ
22. Shiao YH, Rugge M, Correa P, Lehmann HP, Scheer WD. p53 alteration in gastric precancerous lesions. Am J Pathol 1994; 144: 511-517
23. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-1181
24. Jones NL, Shannon PT, Cutz E, Yeger H, Sherman PM. Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection. Am J Pathol 1997; 151: 1695-1703
25. Hibi K, Mitomi H, Koizumi W, Tanabe S, Saigenji K, Okayasu I. Enhanced cellular proliferation and p53 accumulation in gastric mucosa chronically infected with Helicobacter pylori. Am J Clin Pathol 1997; 108: 26-34
26. Nardone G, Staibano S, Rocco A, Mezza E, D'armiento FP, Insabato L, Coppola A, Salvatore G, Lucariello A, Figura N, De Rosa G, Budillon G. Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis. Gut 1999; 44: 789-799
27. Satoh K, Kihira K, Kawata H, Tokumaru K, Kumakura Y, Ishino Y, Kawakami S, Inoue K, Kojima T, Satoh Y, Mutoh H, Sugano K. p53 expression in the gastric mucosa. before and after eradication of Helicobacter pylori. Helicobacter 2001; 6: 31-36
28. Teh M, Tan KB, Seet BL, Yeoh KG. Study of p53 immuno-staining in the gastric epithelium of cagA-positive and cagA-negative Helicobacter pylori gastritis. Cancer 2002; 95: 499-505
29. Levine AJ, Finlay CA, Hinds PW. p53 is a tumor suppressor gene. Cell 2004; 116: S67-S69, 1 p following S69
30. Momand J, Zambetti GP. Mdm-2: "big brother" of p53. J Cell Biochem 1997; 64: 343-352
31. Morgan C, Jenkins GJ, Ashton T, Griffiths AP, Baxter JN, Parry EM, Parry JM. Detection of p53 mutations in precancerous gastric tissue. Br J Cancer 2003; 89: 1314-1319
32. Unger Z, Molnar B, Pronai L, Szaleczky E, Zagoni T, Tulassay Z. Mutant p53 expression and apoptotic activity of Helicobacter pylori positive and negative gastritis in correlation with the presence of intestinal metaplasia. Eur J Gastroenterol Hepatol 2003; 15: 389-393
33. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52: 6735-6740
34. Murakami K, Kodama M, Sato R, Okimoto T, Watanabe K, Fujioka T. Helicobacter pylori eradication and associated changes in the gastric mucosa. Expert Rev Anti Infect Ther 2005; 3: 757-764